On the other hand, Rossi et al. observed that the use of interleukin 4 (IL-4) in mSOD1G93A mice can modulate the differentiation of microglia cells towards the M2 phenotype, improving the course of ALS pathology [40]. The gene discussed is IL4; the disease is amyotrophic lateral sclerosis.